chr6-160122053-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003057.3(SLC22A1):c.118G>A(p.Val40Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000768 in 1,613,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003057.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A1 | NM_003057.3 | c.118G>A | p.Val40Ile | missense_variant | 1/11 | ENST00000366963.9 | NP_003048.1 | |
SLC22A1 | NM_153187.2 | c.118G>A | p.Val40Ile | missense_variant | 1/10 | NP_694857.1 | ||
SLC22A1 | XM_005267103.3 | c.118G>A | p.Val40Ile | missense_variant | 1/12 | XP_005267160.1 | ||
SLC22A1 | XM_006715552.3 | c.118G>A | p.Val40Ile | missense_variant | 1/9 | XP_006715615.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A1 | ENST00000366963.9 | c.118G>A | p.Val40Ile | missense_variant | 1/11 | 1 | NM_003057.3 | ENSP00000355930 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251354Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135860
GnomAD4 exome AF: 0.0000780 AC: 114AN: 1461686Hom.: 0 Cov.: 30 AF XY: 0.0000756 AC XY: 55AN XY: 727144
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2023 | The c.118G>A (p.V40I) alteration is located in exon 1 (coding exon 1) of the SLC22A1 gene. This alteration results from a G to A substitution at nucleotide position 118, causing the valine (V) at amino acid position 40 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at